PP01.118 Nivolumab (N) + Ipilimumab (I) + 化疗 (C) 一线治疗转移性 NSCLC (mNSCLC)：CheckMate 9LA 4年临床更新

IF 17.3 1区材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY ACS Nano Pub Date : 2024-07-01 DOI:10.1016/j.jtho.2024.05.343

F. Badin, D. Carbone, T. Ciuleanu, M. Schenker, M. Cobo-Dols, Stéphanie Bordenave, O. Juan-Vidal, J. Menezes, Niels Reinmuth, E. Richardet, Ying Cheng, H. Mizutani, Luis G. Paz-Ares, Shun Lu, T. John, Xiaoqing Zhang, N. Hu, D. Balli, V. Baxi, J. Neely, M. Reck

{"title":"PP01.118 Nivolumab (N) + Ipilimumab (I) + 化疗 (C) 一线治疗转移性 NSCLC (mNSCLC)：CheckMate 9LA 4年临床更新","authors":"F. Badin, D. Carbone, T. Ciuleanu, M. Schenker, M. Cobo-Dols, Stéphanie Bordenave, O. Juan-Vidal, J. Menezes, Niels Reinmuth, E. Richardet, Ying Cheng, H. Mizutani, Luis G. Paz-Ares, Shun Lu, T. John, Xiaoqing Zhang, N. Hu, D. Balli, V. Baxi, J. Neely, M. Reck","doi":"10.1016/j.jtho.2024.05.343","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21,"journal":{"name":"ACS Nano","volume":"66 1","pages":""},"PeriodicalIF":17.3000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PP01.118 First-line Nivolumab (N) + Ipilimumab (I) + Chemotherapy (C) in Metastatic NSCLC (mNSCLC): CheckMate 9LA 4-Year Clinical Update\",\"authors\":\"F. Badin, D. Carbone, T. Ciuleanu, M. Schenker, M. Cobo-Dols, Stéphanie Bordenave, O. Juan-Vidal, J. Menezes, Niels Reinmuth, E. Richardet, Ying Cheng, H. Mizutani, Luis G. Paz-Ares, Shun Lu, T. John, Xiaoqing Zhang, N. Hu, D. Balli, V. Baxi, J. Neely, M. Reck\",\"doi\":\"10.1016/j.jtho.2024.05.343\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":21,\"journal\":{\"name\":\"ACS Nano\",\"volume\":\"66 1\",\"pages\":\"\"},\"PeriodicalIF\":17.3000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Nano\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jtho.2024.05.343\",\"RegionNum\":1,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Nano","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jtho.2024.05.343","RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

PP01.118 First-line Nivolumab (N) + Ipilimumab (I) + Chemotherapy (C) in Metastatic NSCLC (mNSCLC): CheckMate 9LA 4-Year Clinical Update

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

ACS Nano 工程技术-材料科学：综合

CiteScore

26.00

自引率

4.10%

发文量

1627

审稿时长

1.7 months

期刊介绍： ACS Nano, published monthly, serves as an international forum for comprehensive articles on nanoscience and nanotechnology research at the intersections of chemistry, biology, materials science, physics, and engineering. The journal fosters communication among scientists in these communities, facilitating collaboration, new research opportunities, and advancements through discoveries. ACS Nano covers synthesis, assembly, characterization, theory, and simulation of nanostructures, nanobiotechnology, nanofabrication, methods and tools for nanoscience and nanotechnology, and self- and directed-assembly. Alongside original research articles, it offers thorough reviews, perspectives on cutting-edge research, and discussions envisioning the future of nanoscience and nanotechnology.